Price$25.00-0.02 (-0.06%)
01:30 PM02:30 PM
News · 26 weeks53-85%
2025-12-142026-06-07
Mix3490d
- Insider18(53%)
- SEC Filings10(29%)
- Other6(18%)
Latest news
25 items- SECSEC Form SD filed by Avanos Medical Inc.SD - AVANOS MEDICAL, INC. (0001606498) (Filer)
- SECSEC Form PREM14A filed by Avanos Medical Inc.PREM14A - AVANOS MEDICAL, INC. (0001606498) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Avanos Medical Inc.SCHEDULE 13G/A - AVANOS MEDICAL, INC. (0001606498) (Subject)
- INSIDERSEC Form 4 filed by Director Blackford Gary4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- INSIDERSEC Form 4 filed by Director Egbuonu-Davis Lisa4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- INSIDERSEC Form 4 filed by Director Franchini Indrani Lall4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- INSIDERSEC Form 4 filed by Director Oleary Patrick J4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- INSIDERSEC Form 4 filed by Director Shimer Julie Ann4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- SECSEC Form DEFA14A filed by Avanos Medical Inc.DEFA14A - AVANOS MEDICAL, INC. (0001606498) (Filer)
- SECSEC Form 10-Q filed by Avanos Medical Inc.10-Q - AVANOS MEDICAL, INC. (0001606498) (Filer)
- SECAvanos Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - AVANOS MEDICAL, INC. (0001606498) (Filer)
- PRAvanos Medical, Inc. Announces First Quarter 2026 ResultsDelivered double-digit organic growth led by Specialty Nutrition Systems segmentGenerated $0.11 of diluted earnings per share and $0.22 of adjusted diluted earnings per shareOn April 14, 2026, announced the execution of a definitive agreement to be acquired by certain affiliates of American Industrial Partners ("AIP") in an all-cash offer at an enterprise value of $1.272 billionALPHARETTA, Ga., May 5, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported first quarter 2026 financial results. "Building off our strong 2025 results, we delivered solid first quarter p
- INSIDERSVP, Chief Financial Officer Galovan Scott Michael covered exercise/tax liability with 4,228 shares, decreasing direct ownership by 3% to 135,596 units (SEC Form 4) (withholding tax)4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- INSIDERSVP, Operations Delgado Sigfrido covered exercise/tax liability with 4,264 shares, decreasing direct ownership by 7% to 55,741 units (SEC Form 4) (withholding obligation)4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- SECSEC Form DEFA14A filed by Avanos Medical Inc.DEFA14A - AVANOS MEDICAL, INC. (0001606498) (Filer)
- INSIDERSEC Form 4 filed by Pacitti David4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- SECSEC Form DEFA14A filed by Avanos Medical Inc.DEFA14A - AVANOS MEDICAL, INC. (0001606498) (Filer)
- SECSEC Form DEFA14A filed by Avanos Medical Inc.DEFA14A - AVANOS MEDICAL, INC. (0001606498) (Filer)
- SECAvanos Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - AVANOS MEDICAL, INC. (0001606498) (Filer)
- PRAvanos Medical, Inc. Agrees To Be Acquired by American Industrial Partners for Approximately $1.272 BillionAvanos Stockholders To Receive $25.00 Per Share in Cash ALPHARETTA, Ga. and NEW YORK, April 14, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS), a leading medical technology company, today announced it has entered into a definitive agreement to be acquired by affiliates of American Industrial Partners ("AIP"), an operationally-oriented industrials investor, in an all-cash transaction that values Avanos at an enterprise value of approximately $1.272 billion. Under the terms of the agreement, Avanos stockholders will receive $25.00 per share in cash for each share of common
- INSIDERAmendment: SEC Form 4 filed by Delgado Sigfrido4/A - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- INSIDERAmendment: SEC Form 4 filed by Galovan Scott Michael4/A - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- INSIDERAmendment: SEC Form 4 filed by Pacitti David4/A - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- INSIDERAmendment: SEC Form 4 filed by Delgado Sigfrido4/A - AVANOS MEDICAL, INC. (0001606498) (Issuer)
- INSIDERAmendment: SEC Form 4 filed by Pacitti David4/A - AVANOS MEDICAL, INC. (0001606498) (Issuer)
AVNS FAQ
7 questionsWhat does Avanos Medical Inc. do?
Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and...Where does AVNS stock trade?
Avanos Medical Inc. (AVNS) is listed on NYSE.What sector and industry is AVNS in?
Avanos Medical Inc. operates in the Health Care sector, Industrial Specialties industry.When did Avanos Medical Inc. go public?
Avanos Medical Inc. (AVNS) completed its IPO in 2014.What are analysts saying about AVNS?
Avanos Medical Inc. has had 7 recent analyst actions on file. The most recent action was from KeyBanc Capital Markets: Sector Weight on 2023-07-25. Recent price targets range from $3100.00 to $4700.00.What companies are similar to AVNS?
Notable peers in the same industry include ISRG (Intuitive Surgical Inc.), EW (Edwards Lifesciences Corporation), STE (STERIS plc (Ireland)), ZBH (Zimmer Biomet Holdings Inc.), MAS (Masco Corporation). Compare AVNS side-by-side with any of them on Quantisnow.How can I track AVNS on Quantisnow?
Quantisnow aggregates Avanos Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AVNS to receive live email and push alerts on every new disclosure.